查詢結果分析
來源資料
相關文獻
- Elective Neck Irradiation for Nasopharyngeal Carcinoma
- Orbital Invasion in Nasopharyngeal Carcinoma: Evaluation with Computed Tomography and Magnetic Resonance Imaging
- 上頜掀開術切除局部復發之鼻咽癌--三例報告
- 中醫脈診儀應用於鼻咽癌患者接受放射線治療全程之研究
- Detection of Human Papilloma Virus and Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma by Polymerase Chain Reaction
- 以螢光透視錄影吞嚥檢查評估鼻咽癌患者因放射線治療所致之吞嚥功能異常
- 鼻咽癌經放射線治療後的顳葉壞死
- A Phase Ⅱ Study of Neoadjuvant Interferon Alfa-2B and Concurrent Interferon and Radiotherapy in Primary Untreated Undifferentiated Carcinoma of Nasopharynx
- Endobronchial Metastatic Disease
- Digital Clubbing and Hypertrophic Osteoarthropathy--An Early Indicator of Pulmonary Metastasis of Nasopharyngeal Carcinoma: Report of a Case
頁籤選單縮合
題 名 | Elective Neck Irradiation for Nasopharyngeal Carcinoma=鼻咽癌之頸部預防性放射治療 |
---|---|
作 者 | 王重榮; 陳惠君; 黃英彥; 李百勳; | 書刊名 | 長庚醫學 |
卷 期 | 23:7 2000.07[民89.07] |
頁 次 | 頁387-395 |
分類號 | 416.879 |
關鍵詞 | 鼻咽癌; 頸部預防性放射治療; Nasopharyngeal carcinoma; Elective neck irradiation; |
語 文 | 英文(English) |
英文摘要 | Background. This study was conducted to evaluate the effectiveness of elective neck irradiation (ENI) for nasopharyngeal carcinoma (NPC), and to analyze factors associated with ENI failure. Methods. A radiation port covering the side of a neck without gross nodal metastasis was qualified for evaluation of the effectiveness of ENI. From 1988 through 1992, a total of 261 patients with N0 (130 cases), N1 (91 cases), and N3 (40 cases) NPCs were studied. All patients were irradiated with 60Co teletherapy or 10 MV x-ray to a total dose of 46.8 Gy/26 fractions, followed by a boost treatment to the primary site to a total dose of 64.8 to 75.6 Gy/36-42 fractions. All ENI ports received irradiation to a dose of 46.8 to 60.8 Gy. The duration of follow-up was 6 to 10 years, with a median of 8.1 years. Factors associated with to the risk of ENI failure were analyzed. Results. (1) The overall 5-year actuarial local control rate and actuarial survival rate were 74% and 63%, respectively. (2) Among the 261 cases in which ENI treatment was used, the treatment failed in 12 cases, accounting for a crude ENI failure rate of 5%. The overall 5- and 10-year cumulative risk of ENI failure was 5% and 7%, respectively. (3) Time from the start of tratment to ENI failure ranged from 9 to 66 months, with a median of 17 months. (4) Of the 12 patients for whom EMI failed, 11 (92%) had recurrence in the upper neck, and one in the lower neck. (5) Existence of prior failure at the primary site was the only factor significantly correlated with the risk of ENI failure (p<0.001). The 5-year cumulative risk of ENI failure for patients with local failure vs. those without was 16% vs. 1% (p<0.0001). Conclusion. Moderate-dose ENI was highly effective in the control of subclinical disease in the neck for NPC. ENI failure was closely associated with prior failure at the primary site, implying that local primary tumor failure may lead to an increased potential for metastasis to the neck. |
本系統中英文摘要資訊取自各篇刊載內容。